|
Volumn 94, Issue 2, 2005, Pages 226-233
|
A randomized controlled trial of an asthma clinical pathway for children in general practice
|
Author keywords
Asthma; Clinical pathway; General practice; Hospital admissions; Randomized controlled trial
|
Indexed keywords
AMINOPHYLLINE;
ANTIASTHMATIC AGENT;
ANTIHISTAMINIC AGENT;
BECLOMETASONE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
FLUTICASONE;
FORMOTEROL;
IPRATROPIUM BROMIDE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
METHYLXANTHINE DERIVATIVE;
NEDOCROMIL;
PREDNISOLONE;
PREDNISONE;
REDIPRED;
SALBUTAMOL;
SALMETEROL;
THEOPHYLLINE;
ADOLESCENT;
ADULT;
ARTICLE;
ASTHMA;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
EMERGENCY WARD;
FEMALE;
GENERAL PRACTICE;
GENERAL PRACTITIONER;
HOSPITAL ADMISSION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
OUTCOMES RESEARCH;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
ADOLESCENT;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CHILD;
CHILD, PRESCHOOL;
CRITICAL PATHWAYS;
FAMILY PRACTICE;
GUIDELINE ADHERENCE;
HOSPITALIZATION;
HUMANS;
INFANT;
INFANT, NEWBORN;
NEW ZEALAND;
REGRESSION ANALYSIS;
|
EID: 14844295550
PISSN: 08035253
EISSN: 16512227
Source Type: Journal
DOI: 10.1080/08035250410020235 Document Type: Article |
Times cited : (31)
|
References (18)
|